Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

PureTech Health plc PRTC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
72/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$57.00
+219%

PRTC Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for PRTC.

People Also View

OPT
OPT
Opthea Limited
$3.41
+1.49%
 MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
 NUVB
NUVB
Nuvation Bio Inc.
$4.85
+3.19%
 JANX
JANX
Janux Therapeutics, Inc.
$15.24
+2.28%
 ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
 RZLT
RZLT
Rezolute, Inc.
$3.56
-1.36%
 GRPH
GRPH
Graphite Bio, Inc.
$3.18
-2.75%
 MOLN
MOLN
Molecular Partners AG
$4.14
-1.66%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message